Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0699790 (
colon cancer
)
28,837
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
microRNAs (miRNAs/miRs) are a conserved class of endogenous, short non-coding RNAs that post-transcriptionally regulate the expression of genes involved in diverse cellular processes. miR-214 has been reported to be associated with several cancers, including human
colon cancer
. However, the function of miR-214 in
colon cancer
development is poorly understood. In the current study, miR-214 was demonstrated to be downregulated in
colon cancer
tissues compared with healthy colon tissues. Functional studies showed that miR-214 overexpression results in the inhibition of cell viability, colony formation and proliferation, and the induction of cell apoptosis.
ADP-ribosylation factor-like protein 2
(
ARL2
) is predicted to be a target candidate of miR-214. A luciferase reporter assay, western blot analysis and quantitative polymerase chain reaction were performed, which revealed that miR-214 negatively regulates
ARL2
expression by targeting its 3' untranslated region directly. In conclusion, the results of the present study revealed that miR-214 suppresses
colon cancer
cell growth via the suppression of
ARL2
, and indicated that miR-214 may present a significant potential therapeutic target for
colon cancer
.
...
PMID:microRNA-214 functions as a tumor suppressor in human colon cancer via the suppression of ADP-ribosylation factor-like protein 2. 2562 Oct 32